Clinical benefit of cancer drugs approved in Switzerland 2010–2019

Clinical benefit of cancer drugs approved in Switzerland 2010–2019

Show other versions (1)

<h4>Background</h4> It is unknown to what extent cancer drugs approved in Switzerland by the Swissmedic fulfil criteria of clinical benefit according to the European Society of Medical Oncology Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS), the American Society of Clinical...

Full description

Bibliographic Details
Main Authors: Roman Adam, Ariadna Tibau, Consolación Molto Valiente, Boštjan Šeruga, Alberto Ocaña, Eitan Amir, Arnoud J. Templeton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187080/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187080/?tool=EBI

Similar Items